Premium
Advanced glycation end product (AGE)‐immunoreactive materials in chronic prurigo patients receiving a long‐standing haemodialysis
Author(s) -
Fujimoto N.,
Tajima S.
Publication year - 2004
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.0007-0963.2004.05864.x
Subject(s) - medicine , papillary dermis , dermis , advanced glycation end product , prurigo , reticular dermis , pathology , immunohistochemistry , prurigo nodularis , pathogenesis , dermatology , glycation , receptor
Summary We report two patients with chronic prurigo who suffered from chronic renal failure and were treated by haemodialysis. Histological examination of pruritic nodules revealed that the papillary dermis of the lesional skin was eosinophilic and amorphous, and free from dermal cell infiltration. Immunohistochemical study demonstrated that advanced glycation end product (AGE)‐immunoreactive materials accumulated in the papillary dermis of the lesional skin. This immunohistochemical finding was never observed in the nonlesional skin adjacent to prurigo nodules of the present cases, and renal disease‐free prurigo skin ( n = 6) and nonprurigo skin of haemodialysis patients ( n = 3). AGE‐modified materials in the papillary dermis may be related to the pathogenesis of prurigo nodules in the haemodialysis patients.